Angiotensin II receptors are exclusively of the AT1 subtype in cultured human vascular smooth muscle cells.
Schachter
M
M
Department of Clinical Pharmacology, St. Mary's Hospital Medical School, ICSTM, London, UK.
Betteridge
L J
LJ
Hughes
A D
AD
Patel
M K
MK
D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000378:metabolism; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D001667:Binding, Competitive; D001713:Biphenyl Compounds / Q000378:metabolism; D002478:Cells, Cultured; D006801:Humans; D007093:Imidazoles / Q000378:metabolism; D007700:Kinetics; D019808:Losartan; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D009842:Oligopeptides / Q000378:metabolism; D011945:Receptors, Angiotensin / Q000145:classification / Q000378:metabolism*; D012504:Saralasin / Q000378:metabolism; D013777:Tetrazoles / Q000378:metabolism
D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D007093:Imidazoles; D009842:Oligopeptides; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D000804:Angiotensin II; C060894:CGP 42112A; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D012504:Saralasin; D019808:Losartan